| CXSL0900021 | 重组人鼠嵌合抗CD20单克隆抗体注射液 | rituximab | Injection | Biological Products(2) | New Drug Application | 2009-11-12 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2011-08-03 | view |
| CXSL1100047 | 重组全人源抗人表皮生长因子受体单克隆抗体注射液 | | Injection | Biological Products(1) | New Drug Application | 2011-11-10 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2014-02-13 | view |
| CYSB1400070 | 重组人鼠嵌合抗CD20单克隆抗体注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2014-07-11 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2014-10-10 | view |
| CXSL1400061 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2014-07-11 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2016-01-14 | view |
| CXSL1400060 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2014-07-11 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2016-01-14 | view |
| CXSL1300109 | 重组人源化抗H7N9单克隆抗体注射液 | | Injection | Biological Products(1) | New Drug Application | 2014-02-24 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2016-02-19 | view |
| CXSL1500036 | 重组人源化抗VEGF单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2015-06-19 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2016-10-11 | view |
| CXSL1500089 | 重组全人源抗肿瘤坏死因子α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-11-19 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2017-05-22 | view |
| CXSL1700078 | 重组人源化抗VEGF单克隆抗体眼用注射液 | | Injection | Biological Products(2) | New Drug Application | 2017-09-30 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2018-05-08 | view |
| CXSL1800025 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2018-03-06 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2018-07-06 | view |
| CXSL1800067 | 重组全人源抗肿瘤坏死因子α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2018-06-14 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2018-10-15 | view |
| CXSS1900047 | 利珀妥单抗注射液 | ripertamab | Injection | Biological Products(2) | New Drug Application | 2019-12-16 | 神州细胞工程有限公司 | SinoCelltech Ltd | In Review | 2019-12-13 | view |
| CXSS1900049 | 利珀妥单抗注射液 | ripertamab | Injection | Biological Products(2) | New Drug Application | 2019-12-16 | 神州细胞工程有限公司 | SinoCelltech Ltd | In Review | 2019-12-13 | view |
| CXSS1900048 | 利珀妥单抗注射液 | ripertamab | Injection | Biological Products(2) | New Drug Application | 2019-12-16 | 神州细胞工程有限公司 | SinoCelltech Ltd | In Review | 2019-12-13 | view |
| CXSL2000119 | 重组人源化抗VEGF单克隆抗体注射液 | | Injection | Biological Products(2) | New Drug Application | 2020-05-29 | 神州细胞工程有限公司 | SinoCelltech Ltd | In Review | 2020-05-28 | view |
| CXSL2000118 | 重组人源化抗PD-1单克隆抗体注射液 | Recombinant humanized anti-PD-1 monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2020-05-29 | 神州细胞工程有限公司 | SinoCelltech Ltd | In Review | 2020-05-28 | view |
| CXSB2100003 | 重组十四价人乳头瘤病毒疫苗（6,11,16,18,31,33,35,39,45,51,52,56,58,59型）（昆虫细胞） | | Injection | Biological Products(1.1) | Supplementary Application | 2021-01-09 | 神州细胞工程有限公司 | SinoCelltech Ltd | In Review | 2021-01-08 | view |
| CXSS1900042 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2019-11-19 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2021-07-28 | view |
| CXSS1900043 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2019-11-19 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2021-07-28 | view |
